z-logo
open-access-imgOpen Access
Identification of Two New Mutations in the Glucokinase Gene That Result in Maturity-Onset Diabetes of the Young
Author(s) -
Seth D. Marks,
Robert Couch
Publication year - 2010
Publication title -
diabetes care
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.636
H-Index - 363
eISSN - 1935-5548
pISSN - 0149-5992
DOI - 10.2337/dc10-0685
Subject(s) - glucokinase , medicine , maturity onset diabetes of the young , diabetes mellitus , gene , identification (biology) , maturity (psychological) , genetics , mutation , age of onset , endocrinology , type 2 diabetes , biology , disease , psychology , developmental psychology , botany
Glucokinase catalyzes glucose to glucose-6-phosphate conversion in the pancreatic β-cell and is a key regulator of insulin secretion (1). The glucokinase gene ( GCK ) on chromosome 7p15.3–15.1 has 12 exons. GCK heterozygous inactivating mutations result in mild fasting hyperglycemia termed maturity-onset diabetes of the young type 2 (MODY2) or MODY-GCK (MIM # 125851) (2). The mutations result in diminished insulin secretion (3) and possibly decreased hepatic glucose uptake and glycogen synthesis (4). Several hundred inactivating mutations throughout exons 2 to 10 have been described (5). We report two previously undescribed mutations.Both patients were assessed at the Pediatric Diabetes Education Centre, Stollery Children's Hospital, Edmonton, Canada. Glucose and A1C …

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom